Aug 22, 2025 • GlobeNewswire
NEUTRAL
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 )
SAN CARLOS, Calif., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) ( "Iovance" or the "Company" ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( "TIL" ) therapies for patients with ...
Aug 19, 2025 • Motley Fool
SOMEWHAT-BULLISH
Why Iovance Biotherapeutics Stock Was Climbing Today
One and a half years after getting the nod from the U.S. Food and Drug Administration, its Amtagvi moves forward in a neighboring country.
Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
Intel, Plymouth Industrial REIT, Premier And Other Big Stocks Moving Higher On Tuesday - Heartland Express ( NASDAQ:HTLD ) , Intel ( NASDAQ:INTC )
U.S. stocks were mixed, with the Dow Jones index gaining more than 150 points on Tuesday. Shares of Intel Corporation INTC rose sharply during Tuesday's session after it was announced that Softbank will invest $2 billion in the company.
Aug 19, 2025 • Benzinga
SOMEWHAT-BULLISH
Why Palo Alto Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket - Color Star Tech ( NASDAQ:ADD ) , Adecoagro ( NYSE:AGRO )
Shares of Palo Alto Networks, Inc. PANW rose sharply in pre-market trading as the company reported better-than-expected financial results for the fourth quarter of fiscal 2025 and issued strong guidance for fiscal 2026 after the market closed on Monday.
Aug 18, 2025 • Benzinga
NEUTRAL
Iovance's Amtagvi® ( lifileucel ) Receives Health Canada Approval for Advanced Melanoma - Iovance Biotherapeutics ( NASDAQ:IOVA )
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy SAN CARLOS, Calif., Aug. 18, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc.